Cancer Control & Psychoneuroimmunology Lab

Welcome to the Cancer Control and Psychoneuroimmunology Lab

The Cancer Control and Psychoneuroimmunology Laboratory (CCPL), led by Dr. Michelle Janelsins, is a clinical and translational research lab that is focused on three main project areas from T1-T4 levels of research:

Understanding clinical, psychological, and biological mechanisms of cognitive difficulties in cancer patients
Investigating interventions to alleviate cognitive difficulties in cancer patients
Translational models of cognitive difficulties in cancer

We use a number of multidisciplinary approaches in psychoneuroimmunology, immunology, neuroscience and cognitive science spanning from basic research in animal model and cell culture systems to large cohort studies and randomized clinical trials.

Michelle C. Janelsins-Benton, Ph.D.
Principal Investigator

Research Projects

Lab Members

Collaborators

Policies & Procedures & Equipment

Research Projects

Characterization of cancer-related cognitive impairment in cancer patients and the psychoneuroimmunological impact of cancer treatments on cognitive function

Randomized clinical trials of the effects of exercise and anti-inflammatories on cognitive function in cancer patients

Translational mouse models of cancer-related cognitive impairment

View All Projects

Recent Publications

1. Loh KP
2. Sanapala C
3. Watson EE
4. Jensen-Battaglia M
5. Janelsins MC
6. Klepin HD
7. Schnall R
8. Culakova E
9. Vertino P
10. Susiarjo M
11. Lin PJ
12. Mendler JH
13. Liesveld JL
14. Huselton EJ
15. Taberner K
16. Mohile SG
17. Mustian K
A single-arm pilot study of a mobile health exercise intervention (GO-EXCAP) in older patients with myeloid neoplasms.; Blood advances. 2022 Mar 23.
1. Yilmaz S
2. Janelsins MC
3. Flannery M
4. Culakova E
5. Wells M
6. Lin PJ
7. Loh KP
8. Epstein R
9. Kamen C
10. Kleckner AS
11. Norton SA
12. Plumb S
13. Alberti S
14. Doyle K
15. Porto M
16. Weber M
17. Dukelow N
18. Magnuson A
19. Kehoe LA
20. Nightingale G
21. Jensen-Battaglia M
22. Mustian KM
23. Mohile SG
Protocol paper: Multi-site, cluster-randomized clinical trial for optimizing functional outcomes of older cancer survivors after chemotherapy.; Journal of geriatric oncology. 2022 Mar 12.
1. Belcher EK
2. Culakova E
3. Gilmore NJ
4. Hardy SJ
5. Kleckner AS
6. Kleckner IR
7. Lei L
8. Heckler C
9. Sohn MB
10. Thompson BD
11. Lotta LT
12. Werner ZA
13. Geer J
14. Hopkins JO
15. Corso SW
16. Rich DQ
17. van Wijngaarden E
18. Janelsins MC
Inflammation, Attention, and Processing Speed in Patients with Breast Cancer before and after Chemotherapy.; Journal of the National Cancer Institute. 2022 Feb 04.

View All Publications

Affiliations

Surgery

News

Dr. Michelle Janelsins Awarded Highest Honor for Young Investigators - WXXI News
Dr. Michelle Janelsins Earns Exceptional Investigator Award to Study Chemo-Brain - URMC Newsroom
Dr. Michelle Janelsins NPR Interview - NPR News
Dr. Michelle Janelsins receives Outstanding Young Investigator Award - Multinational Association of Supportive Care in Cancer (MASCC)

Contact Us

Cancer Control & Psychoneuroimmunology Lab
601 Elmwood Ave
Rochester, NY 14642

Michelle_Janelsins@urmc.rochester.edu

(585) 273-1940

Clinical Research:
Kassandra Doyle, B.S.
Clinical Research Coordinator

(585) 276-7142

Basic Research:
Bryan Thompson, B.S.
Technical Associate I

(585) 273-1940